ClinicalTrials.gg
Not yet recruitingNCT07857057FIRST BITESUpdated Oct 5, 2026

Food Introduction for Risk Reduction, Support Tolerance: Behavioral Intervention for Toddler Eating Success

An interventional study of Education and Reminders/Supportive Communication and Education in Food Allergy and Early Allergen Introduction, sponsored by University of Texas Southwestern Medical Center. Not yet recruiting at 3 sites in United States. Open to participants aged 4 Months to 8 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Prevention

How we know

Updated Oct 5, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
4 Months to 8 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 139 studies in Food Hypersensitivity with a site in United States — 19 open to participants now, 28 under way, 3 of them phase 3. Food Hypersensitivity · United States.

Planned enrollment
7th of 105
300 · median 41
Started
2026
with 5 others
No phase
29 of 139
3 open now
Primary completion
2027-04
later than 9 of 27 live
Registered
138th of 139
by date

Among the 139 studies in Food Hypersensitivity with a site in United States, this one is the 7th largest by planned enrollment of the 105 interventional ones that give a count, is one of 6 that started in 2026, is one of 29 with no phase, reaches primary completion later than 9 of the 27 other live ones, and was the 138th registered.

Food Hypersensitivity

378 studies on the registry are indexed under Food Hypersensitivity; 90 are open to participants now.

Browse Food Hypersensitivity studies →

Open to participants now

19 of the 139 studies in Food Hypersensitivity with a site in United States are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 53 Food Hypersensitivity studies recruiting now, 8 (15%) set no upper age limit and 41 (77%) stop at 75 or younger; 45 take children under 18; 17 take healthy volunteers.

This study: 4 Months to 8 Months · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 139 studies in Food Hypersensitivity with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate the feasibility, acceptability, perceived safety, and adherence outcomes of FIRST BITES (Food Introduction for Risk Reduction, Support Tolerance: Behavioral Intervention for Toddler Eating Success), a supervised, community-based early peanut introduction model, in caregiver-infant dyads.

The main questions it aims to answer are:

  • Can eligible caregiver-infant dyads be successfully recruited to and retained in community-based peanut introduction events, and do caregivers find the feeding event, educational materials, and intervention approach acceptable?
  • Does education plus structured behavioral reinforcement improve adherence to peanut feeding recommendations, caregiver self-efficacy, and caregiver anxiety related to early peanut introduction compared with education alone?

Researchers will compare education alone with education plus behavioral reinforcement to determine whether behavioral reinforcement supports continued peanut feeding and improves caregiver confidence following peanut introduction.

Participants will:

  • Attend a supervised community-based peanut introduction event.
  • Receive education about early peanut introduction.
  • Be randomized to receive either education alone or education plus behavioral reinforcement following the feeding event.
  • Complete surveys regarding peanut feeding practices, caregiver self-efficacy, anxiety related to peanut introduction, and perceptions of feasibility, acceptability, and safety.
  • Participate in follow-up assessments during the 6-week intervention period and at 3 months after enrollment.
  • Some participants may be invited to complete qualitative interviews regarding barriers and facilitators to early peanut introduction.
03

Conditions studied

  • Food Allergy
  • Early Allergen Introduction

Browse trials for

Keywords

  • Infant Feeding
  • Caregiver Education
04

Who can participate

Ages eligible
4 Months to 8 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Caregivers:

    • You are 18 years old or older.
    • You are the infant's parent or legal guardian.
    • You are able to give permission for yourself and your infant to participate in the study.
    • You can speak and read English.
    • You are interested in introducing peanut-containing foods to your infant and continuing to feed peanut regularly.
    • You are willing to attend the supervised peanut feeding event and complete study follow-up activities.
    • You are willing to receive study-related reminders and communications by phone, email, or text message.
  • Infants:

    • They are 4 to 8 months old at the time they join the study.
    • They are developmentally ready to safely eat foods by mouth.
    • They have never eaten peanut before.
    • The study team determines that they are an appropriate candidate for supervised peanut introduction.
  • Advisory Panel Participants:

    • You are 18 years of age or older.
    • You are able to provide .
    • You have experience related to one or more of the following: Community feeding events, Behavioral interventions, Pediatric allergy care, Community medical practice, Implementation or program development, Health equity, Participant recruitment and retention, Community engagement
    • You are willing to participate in a virtual discussion group or feedback session that may be audio recorded.

Exclusion criteria

Exclusion Criteria:

  • Caregiver-Infant Pairs

    • The infant has already eaten peanut.
    • The infant has a known peanut allergy or has been diagnosed with a peanut allergy by a doctor.
    • The infant has had a previous reaction that may have been caused by a peanut allergy.
    • The infant has a diagnosed feeding disorder.
    • The infant has a medical, developmental, or feeding condition that could make peanut introduction unsafe or make it difficult to participate in the study.
    • The caregiver is not the infant's parent or legal guardian.
    • The caregiver is unable or unwilling to provide consent for participation.
    • The caregiver is unable to participate in study activities and follow-up assessments in English.
    • The caregiver or infant has another condition or circumstance that the study doctor believes would make participation unsafe, impractical, or not in their best interest.
  • Advisory Panel Participants:

    • You are unable or unwilling to provide .
    • You are unable to participate in the virtual discussion group or feedback session.
    • The study team determines that a conflict of interest, role limitation, or other circumstance makes participation inappropriate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Other
    Education Alone

    Behavioral: Education

  • Other
    Education plus behavioral reinforcement

    Behavioral: Education and Reminders/Supportive Communication

Interventions

  • BehavioralEducation and Reminders/Supportive Communication

    In addition to the supervised community-based peanut introduction event and educational materials, reinforcements will also be added. Behavioral reinforcement may include reminder messages, prompts, and supportive communications intended to encourage adherence to peanut feeding recommendations and increase caregiver confidence with continued peanut introduction.

  • BehavioralEducation

    Educational materials provide guidance on peanut feeding practices and recommendations for continued peanut consumption following the initial supervised introduction.

06

What researchers measure

Primary outcomes

  1. Recruitment, Attendance, Retention, Assessment Completion, and Engagement Rates and Feasibility of Intervention Measure (FIM) Scores

    Feasibility will be assessed using recruitment, enrollment, attendance, retention, and engagement metrics, including the number of families expressing interest, screened, eligible, enrolled, attending a community feeding event, completing supervised peanut introduction, randomized, completing the 6-week assessment, and completing the 3-month assessment. Engagement will be assessed using response rates during weekly text-message check-ins among participants assigned to behavioral reinforcement. Feasibility will also be assessed using the Feasibility of Intervention Measure (FIM), a 4-item participant-reported measure. Total scores range from 4 to 20, with higher scores indicating greater perceived feasibility of the intervention.

    Time frame: Recruitment through Week 6 post-community feeding event (end of intervention)

  2. Acceptability of Community Feeding Events and Behavioral Reinforcement Strategy Measured by Acceptability of Intervention Measure (AIM) Scores and Qualitative Interview Findings

    Acceptability will be assessed using the Acceptability of Intervention Measure (AIM) and qualitative caregiver interview data. The AIM will assess caregiver perceptions of the acceptability of the community feeding event and, for participants assigned to the intervention arm, the 6-week behavioral reinforcement text message program. The AIM is a 4-item participant-reported measure with total scores ranging from 4 to 20, with higher scores indicating greater acceptability. Qualitative interviews will assess caregiver perceptions of the acceptability of the community feeding event, educational materials, peanut preparation demonstration, supervised feeding process, behavioral reinforcement strategy, and follow-up procedures. Interview data will be analyzed to identify caregiver-reported barriers, facilitators, perceived strengths, and suggested refinements.

    Time frame: 6 weeks post-community feeding event (end of intervention)

  3. Caregiver-Reported Comfort, Staff-Observed Safety Events, Adverse Events, Emergency Medical Interventions, and Safety Concerns During Supervised Peanut Introduction

    Perceived safety will be assessed using caregiver-reported comfort with the supervised peanut introduction process, study staff observations during the community feeding event, documentation of observed or reported symptoms and adverse events, emergency medication administration, emergency medical services activation, and caregiver-reported safety concerns. Safety outcomes will be summarized descriptively overall and by study site.

    Time frame: Community feeding event (Day 0), Week 6 post-community feeding event, and Month 3 follow-up.

  4. Caregiver-Reported Peanut Offering, Peanut Ingestion, Feeding Frequency, and Peanut Protein Consumption

    Adherence to ongoing peanut feeding will be assessed using caregiver-reported peanut offering and ingestion. Measures will include whether peanut was offered to the infant, whether the infant ingested peanut, frequency of peanut offering and ingestion, and estimated quantity of peanut protein consumed. Data will be collected at baseline, 6 weeks, and 3 months. For participants assigned to the behavioral reinforcement arm, weekly text-message check-ins during the 6-week intervention period will also be used to assess week-by-week adherence patterns.

    Time frame: Baseline, weekly during Weeks 1-6 for participants assigned to behavioral reinforcement, 6 weeks post-community feeding event, and 3 months post-enrollment.

Secondary outcomes

  1. Caregiver Self-Efficacy Measured by the PROMIS General Self-Efficacy Scale

    Caregiver self-efficacy will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) General Self-Efficacy Scale, a 4-item caregiver-reported measure, and additional study-specific items related to caregiver confidence in introducing and maintaining peanut in the infant's diet. PROMIS General Self-Efficacy Scale total scores range from 4 to 20, with higher scores indicating greater self-efficacy and confidence in managing challenges related to infant peanut introduction and feeding.

    Time frame: Baseline (Day 0/community feeding event), Week 6 post-community feeding event, and Month 3 follow-up

  2. Caregiver Anxiety Measured by PROMIS Caregiver Anxiety Scale Scores

    Caregiver anxiety will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Caregiver Anxiety Scale, an 8-item caregiver-reported measure. Total scores range from 8 to 40, with higher scores indicating greater anxiety and more severe anxiety symptoms. Scores will be summarized and compared across study assessment time points.

    Time frame: Baseline (Day 0/community feeding event), Week 6 post-community feeding event, and Month 3 follow-up

07

Study locations

3 sites
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made available to external researchers. Data sharing will be limited to authorized study personnel at participating sites as necessary for study conduct, safety monitoring, regulatory compliance, and reporting.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Apr 2027, 6 months later.

Of 82 non-industry interventional studies with no phase under Food Hypersensitivity, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 50. This study's planned 6 months is below that.

Counting every sponsor, half of 86 studies reached it within 30 months; a quarter within 13 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 24, 2026
First posted
Oct 5, 2026
StartEst.
Oct 2026
Primary completionEst.
Apr 2027
CompletionEst.
Jun 30, 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07857057
Collaborators
American College of Allergy, Asthma and Immunology
Responsible party
Drew Bird (Professor of Pediatrics, Division of Allergy and Immunology, University of Texas Southwestern Medical Center) — Principal investigator
First posted
Oct 5, 2026
Start date
Oct 2026 (estimated)
Primary completion
Apr 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

John Bird, MD
principal investigator · University of Texas Southwestern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion